FIELD: medicine, pharmaceutics.
SUBSTANCE: what is offered is application of 1-aminoalkylcyclohexane neramexane derivative or its salts for treating or preventing tinnitus, where treatment takes place within three to twelve months since presentation of tinnitus (subacute tinnitus) (versions), a related method of treating, and a pharmaceutical composition of the same purpose containing neramexane or its salts in a combination with an auxiliary pharmaceutical agent selected from antidepressants or anxiolytics, dopamine antagonists, alpha2delta-ligands and NK1 antagonists.
EFFECT: clinical effectiveness and safety before the stage of centralisation of the diseases, the patients appeared to show a good response on neramexane therapy.
21 cl, 1 dwg, 9 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| NERAMEXANE TITRATION KIT AND USING IT IN TREATING INTERNAL EAR DISORDERS | 2008 |
|
RU2459618C2 |
| INTERVAL THERAPY FOR TREATING TINNITUS | 2008 |
|
RU2446794C2 |
| 1-AMINOALKYLCYCLOHEXANE DERIVATIVES FOR TREATING AND PREVENTING HEARING LOSS | 2008 |
|
RU2452476C2 |
| 1-AMINOALKYLCYCLOHEXANE DERIVATIVES FOR TREATMENT OF INFLAMMATORY SKIN DISEASES | 2009 |
|
RU2481828C2 |
| NEW COMBINATIONS OF NERAMEXANE FOR TREATING NEURODEGENERATIVE DISORDERS | 2008 |
|
RU2432161C1 |
| DERIVATIVES OF 1-AMINO-ALKYLCYCLOHEXANE FOR TREATMENT OF DISEASES, MEDIATED BY MAST CELLS | 2009 |
|
RU2484813C2 |
| MATRIX TABLET WITH MODIFIED NERAMEXANE RELEASE | 2006 |
|
RU2422135C2 |
| METHODS FOR THE TREATMENT OF COCHLEAR SYNAPTOPATHY | 2017 |
|
RU2757276C2 |
| SYNTHESIS OF 1-AMINO-1,3,3,5,5-PENTAMETHYLCYCLOHEXANE MESYLATE | 2010 |
|
RU2513090C2 |
| METHOD OF TREATING THERMOREGULATION DISORDER | 2007 |
|
RU2478379C2 |
